Acura Settles Shareholder Claims Over Acurox For $1.5M

Law360, New York (January 24, 2012, 3:54 PM EST) -- Acura Pharmaceuticals Inc. on Monday agreed to pay $1.5 million to resolve a putative shareholder class action in Illinois federal court claiming the drugmaker misrepresented the chances that its flagship painkiller Acurox would gain regulatory approval in order to inflate its stock price.

Under the terms of the settlement that the court preliminarily approved on Nov. 8 and lead plaintiff Acura Shareholder Investors Group requested final approval for on Monday, the $1.5 million cash settlement will be distributed among shareholders who purchased or acquired Acura stock...
To view the full article, register now.




Case Information

Case Title

IN RE: Acura Pharmaceuticals, Inc. Securities Litigation

Case Number



Illinois Northern

Nature of Suit



Honorable Virginia M. Kendall

Date Filed

September 10, 2010

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.